Amedica (AMDA) Reports Q3 Loss of $0.30
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/14/2026
- Tech stocks pull Wall Street lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
Amedica Corporation Reports Third Quarter 2016 Financial Results
November 10, 2016 5:31 PM ESTSALT LAKE CITY, UT -- (Marketwired) -- 11/10/16 -- Amedica Corporation (NASDAQ: AMDA), a company that develops and commercializes silicon nitride ceramics as a biomaterial platform, today announced financial results for the third quarter ended September 30, 2016.
Recent Company Highlights
Decreased year-to-date operational cash burn by 25% Received FDA clearance for Valeo II Lateral Lumbar interbody fusion device Submitted 510(k) to FDA for new Taurus metals system with first implantation expected by end of the year The first stage of testing of silicon nitride by the... More